Stock IMM IMMUPHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News ImmuPharma plc

Equities

IMM

GB0033711010

Market Closed - London S.E.
Other stock markets
 11:35:00 2024-05-21 EDT 		5-day change 1st Jan Change
2.205 GBX -1.56% Intraday chart for ImmuPharma plc -7.35% +32.27%
04-29 Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director CI
04-02 Immupharma jumps amid new IP strategy for P140 technology platform AN

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director
CI
Immupharma jumps amid new IP strategy for P140 technology platform
AN
ImmuPharma plc Initiates New Intellectual Property Strategy to Significantly Enhance the Patent Life and Commercial Value for Its P140 Technology Platform
CI
ImmuPharma : Incanthera Provides Commercial Update and Revenue Forecasts
PU
Incanthera says first order from skincare deal doubles
AN
Stocks make tepid start to new week
AN
AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss
AN
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments
AQ
EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up
AN
TR1 – Major Holding by Lanstead (Date: 28 December 2023)
PU
ImmuPharma : TR1 – Major holding by Lanstead
PU
EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows
AN
Immupharma Decides to Move Directly to Late-stage Trial of Lupus Therapy
MT
ImmuPharma Appoints Contract Research Organization for Late-stage Lupuzor Trial
MT
Immupharma plc Announces Key Updates on Its Late Stage P140 Program, in Patients with Systemic Lupuzortm
CI
Incanthera signs skincare stocking deal, raises GBP1 million
AN
ImmuPharma plc Announces Executive Appointments
CI
Immunovia Successfully Completes Discovery Phase of Next-Generation Test Development
CI
ImmuPharma : Major shareholding by Lanstead via TR1
PU
RA International loss narrows as revenue grows
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMM Stock
  4. News ImmuPharma plc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW